
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1045 | 1040 | 1100 | 1133 | 1236 | 1353 |
Fund Return | 4.49% | 4.04% | 9.99% | 4.26% | 4.33% | 3.07% |
Place in category | 132 | 163 | 144 | 161 | 159 | 83 |
% in Category | 26 | 33 | 24 | 36 | 39 | 28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1923635863 | 2.66B | 9.05 | -1.94 | - | ||
LU2000522420 | 2.66B | 12.36 | -6.09 | - | ||
UBSLuxEqSICAV USA Growth H FAcc | 2.58B | -11.03 | 5.05 | 11.54 | ||
LU0508198768 | 2.58B | -11.11 | 4.52 | 10.98 | ||
LU0511785726 | 2.58B | -11.37 | 3.45 | 9.84 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU2258443139 | 2.28B | -2.14 | 1.49 | - | ||
NN L Patrimonial Balanced Europeanp | 621.39M | 2.42 | 2.73 | 2.76 | ||
NN L Patrimonial Balanced Europeane | 621.39M | 2.43 | 2.72 | 2.76 | ||
LU1444115874 | 621.39M | 2.21 | 2.96 | 2.92 | ||
LU1744628287 | 483.55M | 0.83 | 0.43 | - |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UBS (Lux) BFConvert Eurp EUR U-X EUR Inc | LU0415180149 | 19.01 | - | - | |
UBS Lux Equity SICAV - European Opportunity Uncons | LU0549584711 | 18.47 | 40,402.020 | +0.33% | |
UBS(LUX) ES Eurp Hi DivSsEUR U-X-acc | LU0566497789 | 14.49 | - | - | |
UBS Lux Bond SICAV - Convert Global EUR I-X-dist | LU0396332644 | 14.17 | 178.840 | -0.30% | |
Teva Pharmaceutical Finance Netherlands II B.V 7.375% | XS2592804434 | 0.65 | - | - |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Strong Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review